European regulatory perspectives for innovative therapies. (2008)
Ormarsdottir, S, Reginster, Jean-Yves, Abadie, E
The current regulatory requirements offer accelerated assessment of innovative therapies in Europe. Future perspectives include the need for increased interaction between stakeholders in...
European regulatory perspectives for innovative therapies. (2008)
Ormarsdottir, S, Reginster, Jean-Yves, Abadie, E
The current regulatory requirements offer accelerated assessment of innovative therapies in Europe. Future perspectives include the need for increased interaction between stakeholders in...
Altman, RD, Abadie, E, Avouac, B, Bouvenot, G, Branco, J, Bruyère, Olivier, ...
Objective: The Group for the Respect of Ethics and Excellence in Science (GREES) organized a working group to assess the value of time to joint surgery as a potential therapeutic failure outcome...
Background for studies on the treatment of male osteoporosis: state of the art. (2000)
Kaufman, Jean, JOHNELL, O, ABADIE, E, ADAMI, S, AUDRAN, M, AVOUAC, B, ...
Background for studies on the treatment of male osteoporosis: state of the art
Kaufman, J, Johnell, O, Abadie, E, Adami, S, Audran, M, Avouac, B, ...
Male osteoporosis represents an important, although long underestimated, public health problem. Both in men and in women aging is accompanied by continuous bone loss and by an exponential increase in...